调肝运脾方治疗腹泻型肠易激综合征临床研究  被引量:22

Clinical Study of Regulating Liver and Activating Spleen Therapy for Diarrhea-Irritable Bowel Syndrome

在线阅读下载全文

作  者:叶柏[1] 陈静[1] 宁丽琴[1] 刘春[1] 曹婷婷[1] 

机构地区:[1]南京中医药大学附属医院,江苏南京210029

出  处:《南京中医药大学学报》2013年第4期314-316,共3页Journal of Nanjing University of Traditional Chinese Medicine

基  金:江苏省社会发展基金(BS2007094);全国中医学术流派传承工作室建设项目;江苏高校优势学科建设工程资助项目

摘  要:目的评价调肝运脾方治疗腹泻型肠易激综合征(D-IBS)肝郁脾虚证的临床疗效和安全性。方法 96例符合纳入标准的D-IBS患者随机分为治疗组48例和对照组48例,其中治疗组1例和对照组2例在首次就诊后均未来院复诊而脱落。治疗组服用中药调肝运脾方,对照组服用得舒特治疗,2组服药时间均为4周。观察并记录治疗前后D-IBS症状、体征积分变化以及治疗前后的相关检验指标变化。结果在总有效率及愈显率方面,治疗组优于对照组(P<0.05)。2组治疗后症状总积分较治疗前均显著下降(P<0.01),治疗组明显优于对照组,P<0.01。治疗组治疗后各主要症状积分均比治疗前显著下降(P<0.05);对照组除排便不尽感外,各主要症状积分较治疗前也有所改善(P<0.05),但治疗组在腹痛或腹部不适、大便次数、大便性状等症状积分改善方面明显优于对照组(P<0.05)。治疗组及对照组治疗后均未出现任何不良反应,2组患者治疗前后分别检测血常规、尿常规、粪常规、丙氨酸氨基转移酶(ALT)、血尿素氮(BUN)、血清肌酐(Scr),均未发现异常。结论调肝运脾方治疗D-IBS临床疗效显著,具有良好安全性。OBJECTIVE To assess the effect of regulating liver and activating spleen therapy on patients with diarrhea-irri table bowel syndrome (D-IBS) belonging to liver depression and spleen deficiency type as well as its safety.METHODS 96 cases conforming to the including criteria were randomly divided into treatment group and control group with 48 in each.1 case of the treatments and 2 cases of the controls fell off as they did not return visit since the first consultation.The treatment group were given traditional Chinese medical formula Tiaogan Yunpi Fang for regulating liver and activating spleen,the control group were administrated with Deshute.The course of two groups was 4 weeks.Symptoms,signs and tests results of the patients before and after treatment were collected and analyzed.RESULTS The treated patients were better than control patients in total effective rate and recovery rate (P<0.05).Symptom score of both groups significantly decreased after treatment,but the treatment group was superior to the control (P<0.01).The symptom score of treatment group decreased in comparison with that before treatment (P<0.05).All the symptoms of control patients were improved except for non-complete defecation (P <0.05).However,abdominal pain and discomfort,defection frequency,feces property of the treated patients were improved significantly,much better than those of the control (P<0.05).There was no adverse reaction in two groups.Regular blood test,urine test,stool test,ALT,BUN,Scr were not found abnormal.CONCLUSION Tiaogan Yunpi Fang is effective on D -IBS with great safety.

关 键 词:调肝运脾方 肠易激综合征 临床研究 

分 类 号:R256.34[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象